← FDA Drug Approvals (Drugs@FDA)
EKTERLY
NDA · New Drug Application · Sponsor: KALVISTA · Approved 2025-07-03
Drug application
- FDA Application #
NDA219301- Application type
- New Drug Application
- Brand name
- EKTERLY
- Generic name
- SEBETRALSTAT
- Active ingredients
- SEBETRALSTAT
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- KALVISTA
- Manufacturer
- KalVista Pharmaceuticals Ltd
- First approval
- 2025-07-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown